CYTOSORBENTS CORPORATI

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

04 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Reports First Quarter 2024 Results

09 May 2024 16:17:23 By Nasdaq GlobeNewswire

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

26 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

17 Apr 2024 09:45:06 By NetDania Notify

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

17 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

16 Apr 2024 09:57:39 By NetDania Notify

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

14 Mar 2024 16:39:31 By Nasdaq GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

08 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

25 Jan 2024 10:26:32 By NetDania Notify

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

17 Jan 2024 07:15:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

08 Jan 2024 10:16:09 By NetDania Notify

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

28 Dec 2023 09:48:08 By NetDania Notify

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

28 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

13 Dec 2023 09:15:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

09 Nov 2023 16:15:00 By Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the 8th Annual Dawson James Conference

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

27 Sep 2023 07:00:00 By Nasdaq GlobeNewswire